↓ Skip to main content

Cochrane Database of Systematic Reviews

Treatments for secondary postpartum haemorrhage

Overview of attention for article published in Cochrane database of systematic reviews, January 2002
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

1 blog
2 Wikipedia pages


68 Dimensions

Readers on

171 Mendeley
Treatments for secondary postpartum haemorrhage
Published in
Cochrane database of systematic reviews, January 2002
DOI 10.1002/14651858.cd002867
Pubmed ID

Jo Alexander, Peter W Thomas, Jill Sanghera


Secondary postpartum haemorrhage is any abnormal or excessive bleeding from the birth canal occurring between 24 hours and 12 weeks postnatally. In developed countries, two per cent of postnatal women are admitted to hospital with this condition, half of them undergoing uterine surgical evacuation; in developing countries it is a major contributor to maternal death. To evaluate the relative effectiveness and safety of the treatments used for secondary postpartum haemorrhage. We searched the Cochrane Pregnancy and Childbirth Group trials register (May 2001), the Cochrane Controlled Trials Register (The Cochrane Library, issue 2, 2001), MEDLINE (back to 1966) and EMBASE (back to 1988). The National Research Register was also searched. The reference lists of trial reports and reviews were searched by hand. Where possible, further sources were sought from the first named authors of the papers identified. All randomised or quasi randomised comparisons between drug therapies, surgical therapies and placebo or no treatment for the management of secondary postpartum haemorrhage occurring between 24 hours and three months following a pregnancy of at least 24 weeks gestation. Reports of possibly eligible studies were scrutinised by two investigators. The third investigator acted as an advisor/arbitrator. Of the 45 papers identified, none met the inclusion criteria. No information is available from randomised controlled trials to inform the management of women with secondary postpartum haemorrhage. This topic may have received little attention because it is perceived as being associated with maternal morbidity rather than mortality in developed countries; it is only recently that the extent and importance of postnatal maternal morbidity has been recognised. A well designed randomised controlled trial comparing the various drug therapies for women with secondary postpartum haemorrhage against each other and against placebo or no treatment groups is needed.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Unknown 168 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 17%
Student > Ph. D. Student 21 12%
Student > Master 18 11%
Researcher 12 7%
Student > Postgraduate 12 7%
Other 28 16%
Unknown 51 30%
Readers by discipline Count As %
Medicine and Dentistry 69 40%
Nursing and Health Professions 16 9%
Social Sciences 5 3%
Psychology 5 3%
Computer Science 3 2%
Other 14 8%
Unknown 59 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2021.
All research outputs
of 22,663,969 outputs
Outputs from Cochrane database of systematic reviews
of 12,296 outputs
Outputs of similar age
of 123,455 outputs
Outputs of similar age from Cochrane database of systematic reviews
of 36 outputs
Altmetric has tracked 22,663,969 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,455 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.